| scholarly article | Q13442814 |
| P2093 | author name string | Shoshana Yakar | |
| Haim Werner | |||
| Cliff Rosen | |||
| P2860 | cites work | The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma | Q80282025 |
| Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction | Q80432871 | ||
| Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration | Q80638835 | ||
| Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women | Q81210432 | ||
| Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice | Q81414682 | ||
| The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone | Q83221974 | ||
| Identification of a novel heterozygous IGF1 splicing mutation in a large kindred with familial short stature | Q84621849 | ||
| Deficiency of the insulin-like growth factor-binding protein acid-labile subunit (ALS) of the circulating ternary complex in children with short stature | Q84639356 | ||
| Selective osteoblast overexpression of IGF-I in mice prevents low protein-induced deterioration of bone strength and material level properties | Q84760341 | ||
| Insulin-Like Growth Factor-Independent Effects of Growth Hormone on Growth Plate Chondrogenesis and Longitudinal Bone Growth | Q87181362 | ||
| Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures | Q34563618 | ||
| Serum IGF-1 affects skeletal acquisition in a temporal and compartment-specific manner | Q34698741 | ||
| A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men | Q34701112 | ||
| Increased serum IGF-1 levels protect the musculoskeletal system but are associated with elevated oxidative stress markers and increased mortality independent of tissue igf1 gene expression | Q34981199 | ||
| Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain | Q35040783 | ||
| Sex-specific regulation of body size and bone slenderness by the acid labile subunit | Q35054359 | ||
| Elevated serum IGF-1 levels synergize PTH action on the skeleton only when the tissue IGF-1 axis is intact. | Q35054363 | ||
| Liver-derived IGF-I contributes to GH-dependent increases in lean mass and bone mineral density in mice with comparable levels of circulating GH. | Q35073629 | ||
| Elevated serum levels of IGF-1 are sufficient to establish normal body size and skeletal properties even in the absence of tissue IGF-1. | Q35155509 | ||
| Growth hormone protects against ovariectomy-induced bone loss in states of low circulating insulin-like growth factor (IGF-1). | Q35156229 | ||
| Insulin-like growth factor (IGF)-I and IGF-II contribute differentially to the phenotype of pregnancy associated plasma protein-A knock-out mice | Q35209511 | ||
| The molecular and cellular biology of insulin-like growth factor II | Q35223922 | ||
| Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation | Q35229856 | ||
| Unbound (bioavailable) IGF1 enhances somatic growth. | Q35232634 | ||
| Hedgehog signaling activates a positive feedback mechanism involving insulin-like growth factors to induce osteoblast differentiation. | Q35485124 | ||
| Two insulin-like growth factor I messenger RNAs are expressed in human liver | Q35583911 | ||
| Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone | Q35752203 | ||
| IGF-1 Receptor Insufficiency Leads to Age-Dependent Attenuation of Osteoblast Differentiation | Q35878802 | ||
| Skeletal hormones and the C/EBP and Runx transcription factors: interactions that integrate and redefine gene expression | Q35940237 | ||
| Effect of Growth Hormone Treatment on Fractures and Quality of Life in Postmenopausal Osteoporosis: A 10-Year Follow-Up Study | Q36060499 | ||
| Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells | Q36223256 | ||
| Pregnancy-associated plasma protein-A modulates the anabolic effects of parathyroid hormone in mouse bone | Q36269335 | ||
| IGF, IGF receptor and overgrowth syndromes. | Q36377721 | ||
| Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice | Q36392687 | ||
| Normal growth and development in the absence of hepatic insulin-like growth factor I | Q36394699 | ||
| Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues | Q36457963 | ||
| DMP-1-mediated Ghr gene recombination compromises skeletal development and impairs skeletal response to intermittent PTH. | Q36466986 | ||
| IGF-1R signaling in chondrocytes modulates growth plate development by interacting with the PTHrP/Ihh pathway | Q36488507 | ||
| Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice | Q36578780 | ||
| Insulin-like growth factor (IGF) binding protein-4 is both a positive and negative regulator of IGF activity in vivo | Q36629279 | ||
| Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models. | Q36734567 | ||
| Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability | Q36759492 | ||
| PTH Promotes Bone Anabolism by Stimulating Aerobic Glycolysis via IGF Signaling | Q36779829 | ||
| IGF-1 Regulates Vertebral Bone Aging Through Sex-Specific and Time-Dependent Mechanisms | Q36862625 | ||
| Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system | Q24681712 | ||
| Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene | Q28118453 | ||
| Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma | Q28188364 | ||
| Insulin-like growth factor II (IGF-II) | Q28281165 | ||
| Effects of human growth hormone in men over 60 years old | Q28288413 | ||
| Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5 | Q28506469 | ||
| Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures | Q28618638 | ||
| Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease | Q28618665 | ||
| Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 | ||
| Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) | Q29619910 | ||
| Bone Mineral Accrual Is Associated With Parathyroid Hormone and 1,25-Dihydroxyvitamin D Levels in Children and Adolescents | Q30278911 | ||
| Gender and sexual maturation-dependent contrasts in the neuroregulation of growth hormone secretion in prepubertal and late adolescent males and females--a general clinical research center-based study | Q30305866 | ||
| The Impact of Gonadal Steroid Hormone Action on Growth Hormone Secretion During Childhood and Adolescence* | Q30438131 | ||
| Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys | Q30460323 | ||
| Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchiectomized rats | Q30697628 | ||
| Regulation of Start Site Usage in the Leader Exons of the Rat Insulin-Like Growth Factor-I Gene by Development, Fasting, and Diabetes | Q30834006 | ||
| Effect of insulin-like growth factor-1 (IGF-1) plus alendronate on bone density during puberty in IGF-1-deficient MIDI mice | Q31070867 | ||
| Surviving endoplasmic reticulum stress is coupled to altered chondrocyte differentiation and function | Q33273633 | ||
| Disruption of insulin-like growth factor-I expression in type IIalphaI collagen-expressing cells reduces bone length and width in mice | Q33285460 | ||
| Insulin-like growth factors in human breast cancer. | Q33538445 | ||
| Relation between insulin-like growth factor-I concentrations, osteoarthritis, bone density, and fractures in the general population: the Chingford study | Q33579491 | ||
| Does the GH/IGF-1 axis contribute to skeletal sexual dimorphism? Evidence from mouse studies. | Q33846089 | ||
| Regulation by fasting of rat insulin-like growth factor I and its receptor. Effects on gene expression and binding | Q33848600 | ||
| Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities | Q33927109 | ||
| Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice | Q33962148 | ||
| Pregnancy-associated plasma protein-A increases osteoblast proliferation in vitro and bone formation in vivo | Q33996924 | ||
| Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences | Q34074066 | ||
| Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms | Q34074077 | ||
| Circulating levels of IGF-1 directly regulate bone growth and density | Q34149771 | ||
| A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. | Q34241257 | ||
| The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin | Q34255489 | ||
| Cortical and trabecular bone mineral loss from the spine and hip in long-duration spaceflight | Q34318541 | ||
| Fluid shear stress induces beta-catenin signaling in osteoblasts. | Q40481605 | ||
| Parental imprinting and the IGF2 gene | Q40600192 | ||
| Paternally Inherited IGF2 Mutation and Growth Restriction | Q40758391 | ||
| Expression of insulin-like growth factor-I in transgenic mice | Q40768879 | ||
| Parathyroid Hormone Levels in Healthy Children and Adolescents | Q40773215 | ||
| Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study | Q40832005 | ||
| IGF-I Signaling in Osterix-Expressing Cells Regulates Secondary Ossification Center Formation, Growth Plate Maturation, and Metaphyseal Formation During Postnatal Bone Development | Q40901506 | ||
| Growth hormone-mediated regulation of insulin-like growth factor I promoter activity in C6 glioma cells | Q40945276 | ||
| Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. | Q41066237 | ||
| The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action | Q41175229 | ||
| Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function | Q41391211 | ||
| No evidence for reduced spontaneous or growth-hormone-stimulated serum levels of insulin-like growth factor (IGF)-I, IGF-II or IGF binding protein 3 in women with spinal osteoporosis | Q41662754 | ||
| Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 levels in aging and age-associated diseases | Q41693119 | ||
| The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene | Q41727244 | ||
| Insulin-like growth factor-I and insulin-like growth factor-II induce c-fos in mouse osteoblastic cells | Q41739461 | ||
| Osx-Cre targets multiple cell types besides osteoblast lineage in postnatal mice | Q41874233 | ||
| Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation | Q41920574 | ||
| Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene | Q41927570 | ||
| Short Stature Associated with a Novel Heterozygous Mutation in theInsulin-Like Growth Factor 1Gene | Q41936501 | ||
| Partial primary deficiency of insulin-like growth factor (IGF)-I activity associated with IGF1 mutation demonstrates its critical role in growth and brain development. | Q41937526 | ||
| Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation | Q42475736 | ||
| Characterization of the receptor for insulin-like growth factor II in bone cells | Q42493147 | ||
| Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone | Q42525601 | ||
| Treatment With Recombinant Human Insulin-Like Growth Factor-1 Improves Growth in Patients With PAPP-A2 Deficiency | Q43120001 | ||
| Identification of IGFBP-3 fragments generated by KLK2 and prevention of fragmentation by KLK2-inhibiting peptides | Q43151753 | ||
| Dihydrotestosterone is a determinant of calcaneal bone mineral density in men. | Q43280600 | ||
| Perturbations in Bone Formation and Resorption in Insulin-Like Growth Factor Binding Protein-3 Transgenic Mice | Q43453827 | ||
| Insulin-like growth factor-I supports formation and activation of osteoclasts | Q43458688 | ||
| Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice | Q43584843 | ||
| Circulating levels of insulin-like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density | Q43586173 | ||
| Homozygous mutation of the IGF1 receptor gene in a patient with severe pre- and postnatal growth failure and congenital malformations | Q43641976 | ||
| Experimental IGF-I receptor deficiency generates a sexually dimorphic pattern of organ-specific growth deficits in mice, affecting fat tissue in particular. | Q43743266 | ||
| PTH differentially regulates expression of RANKL and OPG. | Q43832667 | ||
| Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men. | Q43926688 | ||
| Increased fracture frequency in adult patients with hypopituitarism and GH deficiency | Q44025099 | ||
| Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis | Q44090259 | ||
| Bone formation in the context of growth retardation induced by hIGFBP-1 overexpression in transgenic mice. | Q44254001 | ||
| Regulation by growth hormone of number of chondrocytes containing IGF-I in rat growth plate | Q44327491 | ||
| IGF2 modulates the microenvironment for osteoclastogenesis | Q44571146 | ||
| The skeletal structure of insulin-like growth factor I-deficient mice | Q44588867 | ||
| An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone | Q44618886 | ||
| Cell proliferation activities on skin fibroblasts from a short child with absence of one copy of the type 1 insulin-like growth factor receptor (IGF1R) gene and a tall child with three copies of the IGF1R gene | Q44690326 | ||
| Sox9/Sox6 and Sp1 are involved in the insulin-like growth factor-I-mediated upregulation of human type II collagen gene expression in articular chondrocytes. | Q44777062 | ||
| Skeletal unloading induces resistance to insulin-like growth factor-I (IGF-I) by inhibiting activation of the IGF-I signaling pathways | Q44812041 | ||
| A potentially deleterious role of IGFBP-2 on bone density in aging men and women | Q44920762 | ||
| Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study. | Q44979340 | ||
| Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women | Q45063585 | ||
| Primary structure of human insulin-like growth factor II. | Q45064062 | ||
| Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity. | Q45759821 | ||
| A New Homozygous IGF1R Variant Defines a Clinically Recognizable Incomplete Dominant form of SHORT Syndrome. | Q45938326 | ||
| Skeletal unloading induces resistance to insulin-like growth factor I on bone formation. | Q45989753 | ||
| Up-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in C57BL/6J osteoblasts as opposed to C3H/HeJ osteoblasts in part contributes to the differential anabolic response to fluid shear | Q46072489 | ||
| Role of IGF-I signaling in regulating osteoclastogenesis | Q46171428 | ||
| Effects of short term administration of recombinant human growth hormone to elderly people | Q46191802 | ||
| Insulin-like growth factor binding protein (IGFBP-1) involvement in intrauterine growth retardation: study on IGFBP-1 overexpressing transgenic mice | Q46281570 | ||
| Insulin-like growth factor I stimulates recovery of bone lost after a period of skeletal unloading. | Q46324113 | ||
| Severe intrauterine growth retardation and atypical diabetes associated with a translocation breakpoint disrupting regulation of the insulin-like growth factor 2 gene | Q46410636 | ||
| Insulin-like growth factor-I treatment in primary growth hormone insensitivity: effect of recombinant human IGF-I (rhIGF-I) and rhIGF-I/rhIGF-binding protein-3 complex | Q46490214 | ||
| Skeletal unloading induces resistance to insulin-like growth factor I. | Q46495116 | ||
| Gender-Specific Differences in the Skeletal Response to Continuous PTH in Mice Lacking the IGF1 Receptor in Mature Osteoblasts | Q46693517 | ||
| The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. . | Q53328360 | ||
| Pregnancy associated plasma protein-A is necessary for expeditious fracture healing in mice. | Q53568079 | ||
| Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. | Q53612569 | ||
| Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. | Q53971094 | ||
| Parental imprinting of the mouse insulin-like growth factor II gene. | Q55052428 | ||
| Mechano-transduction in osteoblastic cells involves strain-regulated estrogen receptor alpha-mediated control of insulin-like growth factor (IGF) I receptor sensitivity to Ambient IGF, leading to phosphatidylinositol 3-kinase/AKT-dependent Wnt/LRP5 | Q55216568 | ||
| Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone r | Q56883933 | ||
| A targeted partial invalidation of the insulin-like growth factor I receptor gene in mice causes a postnatal growth deficit | Q56901705 | ||
| High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly | Q57250965 | ||
| Parallel-plate fluid flow systems for bone cell stimulation | Q57633489 | ||
| Somatomedin: Proposed Designation for Sulphation Factor | Q59080510 | ||
| Congenic Mice Providein VivoEvidence for a Genetic Locus that Modulates Serum Insulin-Like Growth Factor-I and Bone Acquisition | Q62723163 | ||
| Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism | Q67516243 | ||
| Growth enhancement of transgenic mice expressing human insulin-like growth factor I | Q67979226 | ||
| Osteoclast formation together with interleukin-6 production in mouse long bones is increased by insulin-like growth factor-I | Q68096397 | ||
| Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae | Q68097816 | ||
| Subcellular location of IGF-I in chondrocytes from rat rib growth plate | Q68158968 | ||
| Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II | Q68431796 | ||
| Regulation by GH of insulin-like growth factor-I mRNA expression in rat epiphyseal growth plate as studied with in-situ hybridization | Q68509750 | ||
| Plasma clearance of chicken and human insulin-like growth factor-I and their association with circulating binding proteins in chickens | Q68768728 | ||
| Human somatomedin. Determination, occurrence, biological activity and purification | Q69099474 | ||
| Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I in rats | Q70120018 | ||
| Differential expression of insulin-like growth factor-I (IGF-I) and IGF-II messenger ribonucleic acid in growing rat bone | Q70577706 | ||
| Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty | Q70660395 | ||
| Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women | Q71053201 | ||
| Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome--a clinical research center study. GHIS Collaborative Group | Q71477205 | ||
| Proteolysis of insulin-like growth factor binding protein-3 during rat pregnancy: a role for matrix metalloproteinases | Q71661124 | ||
| Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells | Q71679363 | ||
| A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency | Q71687669 | ||
| Further Purification and Characterization of Sulfation Factor and Thymidine Factor from Acromegalic Plasma | Q71752023 | ||
| Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats | Q72326673 | ||
| Insulin-like growth factor I supports differentiation of cultured osteoblast-like cells | Q72385551 | ||
| Increased insulin-like growth factor I mRNA expression in rat osteocytes in response to mechanical stimulation | Q72564734 | ||
| Mitogenic responsiveness of human bone cells in vitro to hormones and growth factors decreases with age | Q72824088 | ||
| Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency | Q73047841 | ||
| Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis | Q73321928 | ||
| Biodistribution of 125I-labeled des(1-3) insulin-like growth factor I in tumor-bearing nude mice and its in vitro catabolism | Q73470643 | ||
| Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: a clinical research center study | Q73739015 | ||
| Effects of estrogen and growth hormone on skeleton in the ovariectomized rat with hypophysectomy | Q73847716 | ||
| Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation | Q73941872 | ||
| Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study | Q74141058 | ||
| Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism | Q74352435 | ||
| Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation | Q74411385 | ||
| Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization | Q74742272 | ||
| Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia | Q74805663 | ||
| Growth hormone increases vertebral and femoral bone strength in osteopenic, ovariectomized, aged rats in a dose-dependent and site-specific manner | Q77379161 | ||
| Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly | Q77767545 | ||
| Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture | Q46716371 | ||
| Prevalence of vertebral fractures in men with acromegaly. | Q46721207 | ||
| Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging | Q46732168 | ||
| Vertebral fracture assessment in acromegaly | Q46759557 | ||
| IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone | Q46771350 | ||
| Effect of GnRH analogue on height potential in patients with severe growth hormone insensitivity syndrome treated with IGF-I. | Q46780650 | ||
| Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of hepatic IGF-I synthesis | Q46809661 | ||
| The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women | Q46972658 | ||
| Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain | Q47252551 | ||
| Postnatally elevated levels of insulin-like growth factor (IGF)-II fail to rescue the dwarfism of IGF-I-deficient mice except kidney weight | Q47319737 | ||
| Insulin-like growth factor I improves height in growth hormone insensitivity: two years' results | Q47361981 | ||
| An essential role for IGF2 in cartilage development and glucose metabolism during postnatal long bone growth. | Q47604904 | ||
| Disrupting IGF Signaling in Adult Mice Conditions Leanness, Resilient Energy Metabolism, and High Growth Hormone Pulses. | Q47840400 | ||
| Hypoxic stress enhances osteoclast differentiation via increasing IGF2 production by non-osteoclastic cells | Q47849526 | ||
| Stimulation of bone formation in vivo by insulin-like growth factor-II in rats | Q47953304 | ||
| Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency | Q47976499 | ||
| Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome | Q48126284 | ||
| IGF-1 Receptor Expression on Circulating Osteoblast Progenitor Cells Predicts Tissue-Based Bone Formation Rate and Response to Teriparatide in Premenopausal Women With Idiopathic Osteoporosis. | Q48218486 | ||
| Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I) and an analogue LR3IGF-I in pregnant rats | Q48245415 | ||
| Microarray analysis of the in vivo effects of hypophysectomy and growth hormone treatment on gene expression in the rat. | Q48835553 | ||
| Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice | Q48901708 | ||
| Cellular pattern of insulin-like growth factor-I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression | Q48909407 | ||
| An experimental model of partial insulin-like growth factor-1 deficiency in mice | Q49022188 | ||
| The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion | Q49086583 | ||
| Disruption of the insulin-like growth factor-1 gene in osteocytes impairs developmental bone growth in mice. | Q50782082 | ||
| Short-term effects of high dose estrogen on tibiae of growing male rats. | Q50974261 | ||
| The effect of hypophysectomy and growth hormone on the incorporation of labeled sulfate into tibial epiphyseal and nasal cartilage of the rat. | Q51331778 | ||
| Bioassay of hypophyseal growth hormone; the tibia test. | Q51361746 | ||
| Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. | Q51586289 | ||
| Three year IGF-I treatment of children with Laron syndrome. | Q51587258 | ||
| Effect of mechanical loading on insulin-like growth factor-I gene expression in rat tibia. | Q51771247 | ||
| Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis. | Q51819758 | ||
| Postnatal growth and bone mass in mice with IGF-I haploinsufficiency. | Q51822603 | ||
| Disruption of insulin-like growth factor-II imprinting during embryonic development rescues the dwarf phenotype of mice null for pregnancy-associated plasma protein-A. | Q52042509 | ||
| Effects of liver-derived insulin-like growth factor I on bone metabolism in mice. | Q52112899 | ||
| Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. | Q52142765 | ||
| Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy. | Q52173480 | ||
| Hemizygosity at the insulin-like growth factor I receptor (IGF1R) locus and growth failure in the ring chromosome 15 syndrome. | Q52510631 | ||
| Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome. | Q52517385 | ||
| Endocrinology--the way we were: a personal history of somatomedin. | Q53245222 | ||
| Effects of insulin-like growth factor binding proteins in bone -- a matter of cell and site | Q36964578 | ||
| The somatomedin hypothesis 2007: 50 years later | Q36994835 | ||
| Insulin-like growth factor-1 receptor in mature osteoblasts is required for periosteal bone formation induced by reloading | Q37105615 | ||
| Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism | Q37123969 | ||
| Differential effects of IGF-1 deficiency during the life span on structural and biomechanical properties in the tibia of aged mice | Q37219630 | ||
| Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions | Q37283796 | ||
| Serum IGF-1 is insufficient to restore skeletal size in the total absence of the growth hormone receptor | Q37349402 | ||
| A novel deletion of IGF1 in a patient with idiopathic short stature provides insight Into IGF1 haploinsufficiency. | Q37428944 | ||
| Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences. | Q37591754 | ||
| Immobilization and bone structure in humans | Q37773475 | ||
| IGF1R mutations as cause of SGA. | Q37852215 | ||
| Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer | Q37941372 | ||
| IGF-1 and BRCA1 signalling pathways in familial cancer | Q38062611 | ||
| Molecular IGF-1 and IGF-1 receptor defects: from genetics to clinical management | Q38079960 | ||
| Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation | Q38308154 | ||
| Elevated circulating insulin-like growth factor binding protein-1 is sufficient to cause fetal growth restriction | Q38318680 | ||
| Structural and functional analysis of the insulin-like growth factor I receptor gene promoter | Q38325320 | ||
| Characterization of the rat insulin-like growth factor I gene promoters and identification of a minimal exon 2 promoter | Q38347482 | ||
| Paracrine Overexpression of IGFBP‐4 in Osteoblasts of Transgenic Mice Decreases Bone Turnover and Causes Global Growth Retardation | Q38354878 | ||
| The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60. | Q38527424 | ||
| 60 YEARS OF NEUROENDOCRINOLOGY: Acromegaly | Q38542023 | ||
| Large-scale analysis of variation in the insulin-like growth factor family in humans reveals rare disease links and common polymorphisms. | Q38847165 | ||
| Unintended targeting of Dmp1-Cre reveals a critical role for Bmpr1a signaling in the gastrointestinal mesenchyme of adult mice | Q38977757 | ||
| Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon | Q39104777 | ||
| The Relationship Between Calciotropic Hormones, IGF-1, and Bone Mass Across Pubertal Stages | Q39346765 | ||
| Early activation of the beta-catenin pathway in osteocytes is mediated by nitric oxide, phosphatidyl inositol-3 kinase/Akt, and focal adhesion kinase | Q39774749 | ||
| A dual effector theory of growth-hormone action | Q39837319 | ||
| Regulation of rapid signal transducer and activator of transcription-5 phosphorylation in the resting cells of the growth plate and in the liver by growth hormone and feeding. | Q39862209 | ||
| Reduced serum IGF-1 associated with hepatic osteodystrophy is a main determinant of low cortical but not trabecular bone mass | Q40043672 | ||
| Signaling mechanisms leading to regulation of proliferation and differentiation of the mesenchymal chondrogenic cell line RCJ3.1C5.18 in response to IGF-I. | Q40143543 | ||
| Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling | Q40286652 | ||
| P921 | main subject | preproinsulin | Q7240673 |
| P577 | publication date | 2018-04-06 | |
| P1433 | published in | Journal of Molecular Endocrinology | Q15716709 |
| P1476 | title | Insulin-like growth factors: actions on the skeleton. |
| Q92445909 | "Bridging the Gap" Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era |
| Q93216872 | A simple method based on confocal microscopy and thick sections recognizes seven subphases in growth plate chondrocytes |
| Q97645481 | Association between Visceral Fat and Bone Mineral Density in Both Male and Female Patients with Adult Growth Hormone Deficiency |
| Q64931144 | Bone microarchitecture and volumetric bone density impairment in young male adults with childhood-onset growth hormone deficiency. |
| Q102052576 | Dietary protein and bone health: towards a synthesised view |
| Q91637134 | Effects of 24 Weeks of Growth Hormone Treatment on Bone Microstructure and Volumetric Bone Density in Patients with Childhood-Onset Adult GH Deficiency |
| Q54110794 | Growth Hormone Receptor Mutations Related to Individual Dwarfism. |
| Q93028189 | Integrated K+ channel and K+Cl- cotransporter functions are required for the coordination of size and proportion during development |
| Q92051625 | Neuron-specific Mafb knockout causes growth retardation accompanied by an impaired growth hormone/insulin-like growth factor I axis |
| Q90460170 | Osteoporosis from an Endocrine Perspective: The Role of Hormonal Changes in the Elderly |
| Q91567200 | Oxygen and embryonic growth: the role of insulin-like growth factor signaling |
| Q90740037 | The Spectrum of Fundamental Basic Science Discoveries Contributing to Organismal Aging |
| Q89013318 | World leaders describe the latest in IGF research |
Search more.